FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520896189> ?p ?o ?g. }

• W1520896189 endingPage "159" @default.
• W1520896189 startingPage "152" @default.
• W1520896189 abstract "What's known on the subject? and What does the study add? There is increasing evidence that the receptor activator of nuclear factor κB ligand ( RANKL ) pathway not only contributes to the development of bone metastases, but also influences tumour biology in earlier stages of cancer. The study shows that preoperative serum levels of RANKL and its inhibitor osteoprotegerin ( OPG ) have a prognostic impact in patients undergoing radical prostatectomy for clinically localized prostate cancer. Both high levels of RANKL and a higher RANKL / OPG ratio are independent predictors of early biochemical recurrence in these patients. Objective To assess the prognostic impact of proteins of the receptor activator of nuclear factor κB ( RANKL ) pathway in serum samples from patients undergoing radical prostatectomy. Patients and Methods We retrospectively determined soluble RANKL ( sRANKL ) and osteoprotegerin ( OPG ) by ELISA in serum samples of 178 patients undergoing radical prostatectomy between 2004 and 2006. Clinical and patient follow‐up data were analysed using the W ilcoxon– M ann– W hitney test, the K aplan– M aier method, and single variable or multifactorial C ox proportional hazards analysis. Results Higher serum sRANKL levels ( P = 0.01), lower serum OPG levels ( P = 0.01) and a higher sRANKL / OPG ratio ( P = 0.004) were significant risk factors for biochemical recurrence ( BCR ). In multifactorial analysis, adjusted for the common risk factors for BCR , sRANKL and sRANKL / OPG ratio were confirmed as independent prognostic factors. Neither sRANKL nor OPG showed a clear association with histopathological factors such as pT stage, pN G leason score or resection margin status, nor were they associated with prostate‐specific antigen level. Conclusions Greater activity of the RANKL pathway in the serum of patients with prostate cancer undergoing radical prostatectomy is a risk factor for BCR . The RANKL pathway seems to contribute to the biological behaviour of prostate cancer even at the organ‐confined stage of the disease." @default.
• W1520896189 created "2016-06-24" @default.
• W1520896189 creator A5004692931 @default.
• W1520896189 creator A5012501589 @default.
• W1520896189 creator A5034310234 @default.
• W1520896189 creator A5053760424 @default.
• W1520896189 creator A5058001714 @default.
• W1520896189 creator A5067369608 @default.
• W1520896189 creator A5067804823 @default.
• W1520896189 creator A5072818969 @default.
• W1520896189 creator A5080662684 @default.
• W1520896189 creator A5086583298 @default.
• W1520896189 creator A5087284396 @default.
• W1520896189 creator A5090616738 @default.
• W1520896189 date "2013-01-29" @default.
• W1520896189 modified "2023-10-04" @default.
• W1520896189 title "Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy" @default.
• W1520896189 cites W1485477721 @default.
• W1520896189 cites W1509085171 @default.
• W1520896189 cites W1528229609 @default.
• W1520896189 cites W1982395713 @default.
• W1520896189 cites W1983145936 @default.
• W1520896189 cites W1984673297 @default.
• W1520896189 cites W1992053982 @default.
• W1520896189 cites W2001609376 @default.
• W1520896189 cites W2003213153 @default.
• W1520896189 cites W2009017218 @default.
• W1520896189 cites W2023398724 @default.
• W1520896189 cites W2041120035 @default.
• W1520896189 cites W2041193073 @default.
• W1520896189 cites W2051328153 @default.
• W1520896189 cites W2055250702 @default.
• W1520896189 cites W2060643795 @default.
• W1520896189 cites W2061144117 @default.
• W1520896189 cites W2080449844 @default.
• W1520896189 cites W2082488224 @default.
• W1520896189 cites W2086008590 @default.
• W1520896189 cites W2088565634 @default.
• W1520896189 cites W2092918046 @default.
• W1520896189 cites W2100281151 @default.
• W1520896189 cites W2102969047 @default.
• W1520896189 cites W2105386786 @default.
• W1520896189 cites W2105863720 @default.
• W1520896189 cites W2110707581 @default.
• W1520896189 cites W2111923037 @default.
• W1520896189 cites W2118834968 @default.
• W1520896189 cites W2122111515 @default.
• W1520896189 cites W2128843508 @default.
• W1520896189 cites W2135463143 @default.
• W1520896189 cites W2139860898 @default.
• W1520896189 cites W2144614118 @default.
• W1520896189 cites W2149696900 @default.
• W1520896189 cites W2152561234 @default.
• W1520896189 cites W2157027180 @default.
• W1520896189 cites W2158111765 @default.
• W1520896189 cites W4293409513 @default.
• W1520896189 doi "https://doi.org/10.1111/j.1464-410x.2012.11759.x" @default.
• W1520896189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23360112" @default.
• W1520896189 hasPublicationYear "2013" @default.
• W1520896189 type Work @default.
• W1520896189 sameAs 1520896189 @default.
• W1520896189 citedByCount "9" @default.
• W1520896189 countsByYear W15208961892014 @default.
• W1520896189 countsByYear W15208961892015 @default.
• W1520896189 countsByYear W15208961892016 @default.
• W1520896189 countsByYear W15208961892017 @default.
• W1520896189 countsByYear W15208961892018 @default.
• W1520896189 crossrefType "journal-article" @default.
• W1520896189 hasAuthorship W1520896189A5004692931 @default.
• W1520896189 hasAuthorship W1520896189A5012501589 @default.
• W1520896189 hasAuthorship W1520896189A5034310234 @default.
• W1520896189 hasAuthorship W1520896189A5053760424 @default.
• W1520896189 hasAuthorship W1520896189A5058001714 @default.
• W1520896189 hasAuthorship W1520896189A5067369608 @default.
• W1520896189 hasAuthorship W1520896189A5067804823 @default.
• W1520896189 hasAuthorship W1520896189A5072818969 @default.
• W1520896189 hasAuthorship W1520896189A5080662684 @default.
• W1520896189 hasAuthorship W1520896189A5086583298 @default.
• W1520896189 hasAuthorship W1520896189A5087284396 @default.
• W1520896189 hasAuthorship W1520896189A5090616738 @default.
• W1520896189 hasConcept C121608353 @default.
• W1520896189 hasConcept C126322002 @default.
• W1520896189 hasConcept C126894567 @default.
• W1520896189 hasConcept C134018914 @default.
• W1520896189 hasConcept C143998085 @default.
• W1520896189 hasConcept C170493617 @default.
• W1520896189 hasConcept C2777008409 @default.
• W1520896189 hasConcept C2779428903 @default.
• W1520896189 hasConcept C2779466945 @default.
• W1520896189 hasConcept C2780192828 @default.
• W1520896189 hasConcept C2780426850 @default.
• W1520896189 hasConcept C71924100 @default.
• W1520896189 hasConcept C88045685 @default.
• W1520896189 hasConceptScore W1520896189C121608353 @default.
• W1520896189 hasConceptScore W1520896189C126322002 @default.
• W1520896189 hasConceptScore W1520896189C126894567 @default.
• W1520896189 hasConceptScore W1520896189C134018914 @default.
• W1520896189 hasConceptScore W1520896189C143998085 @default.

• next